Drug Discovery

AI-driven insights risk becoming another layer of noise if the information being processed is not delivered through reliable and automated data pathways. This fundamental challenge defines the current landscape of biopharmaceutical research, where the rapid adoption of high-resolution imaging,

Network Bio’s debut marks a strategic shift toward solving the biological puzzle holistically rather than focusing on isolated components of individual human diseases. In a landscape where traditional drug discovery often stumbles over the immense complexity of the human body, this company has

The SLICeVLP system decouples guide RNA delivery from Cas9 protein delivery to enable large-scale pooled CRISPR screening in primary human macrophages for the first time. This technological leap addresses a longstanding bottleneck in the field of immunotherapy, where the focus has historically

Establishing a more translationally aligned approach through cross-sector collaboration is essential for identifying neurological risks before a drug reaches human clinical trials. The central nervous system remains the most daunting frontier in drug development due to its sheer structural

The biological monopoly held by the standard twenty amino acids has finally met its match in a laboratory environment that prioritizes chemical versatility over the stubborn requirements of cellular survival. For decades, the progress of synthetic biology was tethered to the growth cycles and

Respiratory motion is not just a byproduct of breathing but a fundamental driver of how the human immune system responds to viral threats. For decades, the medical community struggled to understand why laboratory experiments involving lung infections often failed to match the complex reality of a